Target intelligence / Profile preview

Major histocompatibility complex class I HLA-A*02:01 (HLA-A*02:01)

Target
HLA-A*02:01
Molecular classification
MHC class I, Histocompatibility antigen
01

Overview

HLA-A*02:01 is a specific allele of the HLA-A gene encoding a major histocompatibility complex (MHC) class I molecule, a heterodimer of a polymorphic heavy alpha chain (encoded by HLA-A) non-covalently associated with invariant beta-2-microglobulin. It presents short peptides (typically 8-10 amino acids) from intracellular proteins, such as viral or tumor antigens, on the cell surface for recognition by CD8+ T cells and natural killer cells via T cell receptors or KIRs. The peptide-binding groove features six pockets (A-F) with allotype-specific residues determining anchor preferences (e.g., L/M/I at P2 in pocket B, V/L/I/A at C-terminus in pocket F for HLA-A*02:01). It plays a pivotal role in adaptive immunity, with structural dynamics allowing peptide loading and presentation.

Other names
HLA-A2HLA-A*02
02

Biological functions

Antigen presentationImmune responsePeptide bindingT cell recognition
03

Disease associations

CancerInfectionTransplant rejection
04

Safety considerations

Risk of immune rejection in transplants due to allelic mismatch
05

Biomarkers

HLA-A*02:01 expression or typing for patient selection in T cell therapies

Beyond the preview

Go deeper on Major histocompatibility complex class I HLA-A*02:01 (HLA-A*02:01).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major histocompatibility complex class I HLA-A*02:01 (HLA-A*02:01).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call